Propranolol for severe infantile hemangiomas: Follow-up report

Pediatrics

Volumn 124, Issue 3, 2009, Pages

  Sans, Véronique ^a   De La Roque, Eric Dumas ^a   Berge, Jérôme ^b   Grenier, Nicolas ^b   Boralevi, Franck ^a   Mazereeuw Hautier, Juliette ^c   Lipsker, Dan ^d   Dupuis, Elisabeth ^e   Ezzedine, Khaled ^f   Vergnes, Pierre ^a   Taïeb, Alain ^a   Léauté Labrèze, Christine ^a  

^a Children's Hospital   (France)

^b HÔPITAL PELLEGRIN   (France)

^c CHU PURPAN   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e Department of Dermatology   (France)

^f HÔPITAL SAINT ANDRÉ   (France)

Author keywords

2 adrenergic receptors; Angiogenesis; Corticosteroids; Interferon; Vincristine

Indexed keywords

ADRENALIN; BETAMETHASONE; CORTICOSTEROID; PREDNISONE; PROPRANOLOL;

AGITATION; ARTICLE; ASTHMA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLD CLAMMY SKIN; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART RATE; HEMANGIOMA; HUMAN; HYPERHIDROSIS; INFANT; INFANT DISEASE; INFANTILE HEMANGIOMA; INSOMNIA; MALE; NIGHTMARE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT; SYSTEMIC THERAPY; WHEEZING;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HEMANGIOMA; HUMANS; INFANT; MALE; PROPRANOLOL; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

EID: 70349252008     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-3458     Document Type: Article

References (30)

1. Frieden IJ, Haggstrom A, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol. 2005;22(5):383-406 (Pubitemid 43960991)
2. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003;48(4):477-493
3. Margileth AM, Museles M. Cutaneous hemangiomas in children: diagnosis and conservative management. JAMA. 1965;194(5):523-526
4. Enjolras O, Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol. 1997;14(3):173-179
5. Tanner JL, Dechert MP, Frieden IJ. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics. 1998;101(3):446-452
6. Bennett ML, Fleischer AB, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001;137(9):1208-1213
7. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990;85(4):491-498 (Pubitemid 20108467)
8. Shorr N, Seiff SR. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg. 1986;17(4):229-231 (Pubitemid 16117093)
9. Ezekowitz RAB, Phil CBD, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326(22):1456-1463
10. Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function- and life-threatening infantile hemangioma[in French]. Arch Pediatr. 2004;11(2):99-107
11. Villain E, Denjoy I, Lupoglazoff JM, et al. Low incidence of cardiac events with β-blocking therapy in children with long QT syndrome. Eur Heart J. 2004;25(16):1405-1411 (Pubitemid 39078249)
12. Fritz KI, Bhat AM. Effect of β-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review. J Perinatol. 1998;18(1):38-44
13. Kilian K. Hypertension in neonates causes and treatments. J Perinat Neonatal Nurs. 2003;17(1): 65-74
14. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-2651
15. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for hemangiomas of infancy. J Am Acad Dermatol. 1997;37(4):631-637
16. Bakhach S, Grenier N, Berge J, et al. Color Doppler sonography of superficial capillary hemangiomas [in French][in French]. J Radiol. 2001;82(11):1613-1619
17. Maleville J, Taïeb A, Roubaud E, Sarrat P, Fontan I, Guillet G. Immature cutaneous hemangiomas: epidemiologic study of 351 cases [in French]. Ann Dermatol Venereol. 1985;112(8):603-608
18. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behaviour of endothelial cells from hemangiomas. J Clin Invest. 2001;107(6):745-752 (Pubitemid 32225360)
19. Khan ZA, Boscolo E, Picard A, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest. 2008;118(7):2592-2599 (Pubitemid 351949786)
20. Bielenberg DR, Bucana CD, Sanchez R, Mulliken JB, Folkman J, Fidler IJ. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, INF-β. Int J Oncol. 1999;14(3):401-408
21. Mancini AJ, Smoller BR. Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol. 1996;18(5):505-514
22. Razon MJ, Kraling BM, Mulliken JB, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998;5(2-3):189-195 (Pubitemid 128647894)
23. 2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res. 2005; 97(11):1182-1189
24. D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem. 1997;67(3):353-366 (Pubitemid 27509471)
25. Verhoeckx KC, Doornbos RP, Witkamp RF, van der Greef J, Rodenburg RJ. β-Adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages. Int Immunopharmacol. 2006;6(1):1-7
26. Kleinman ME, Greives MR, Churgin SS, et al. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol. 2007; 27(12):2664-2670
27. Giatromanolaki A, Arvanitidou V, Hatzimichael A, Simopoulos C, Sivridis E. The HIF-2α/VEGF pathway activation in cutaneous capillary hemangiomas. Pathology. 2005;37(2):149-151 (Pubitemid 40593407)
28. Shyu KG, Liou JY, Wang BW, Fang WJ, Chang H. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heart. J Biomed Sci. 2005;12(2):409-420 (Pubitemid 40897646)
29. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38(5):298-304 (Pubitemid 35204978)
30. Love JN, Sikka N. Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med. 2004;26(3):309-314 (Pubitemid 38340830)